Manuel de la Puerta
Medical Oncology · Gainesville, FLNPI 1508851577
Payments from drug & device makers
What this record shows
It is spread thinly across 29 manufacturers, the largest accounting for just 18.1%. Reporting peaked in 2019 at $575 and has fallen 97.5% since, to $14 in 2025. That places this record below the midpoint for medical oncology clinicians in FL, where the typical reported total is $8,890.
Across 54 payments — averaging $32.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$315
- Seagen Inc.$218
- Takeda Pharmaceuticals U.S.A., Inc.$200
- Astellas Pharma US Inc$117
- Incyte Corporation$115
- Clovis Oncology, Inc.$99
- plus $679 from 23 others
Across 6 payments — averaging $2256.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bristol Myers Squibb$14K
What the payments were for
- Food & beverage$71441%
- Education$1,02859%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 6 | $315 |
| Seagen Inc. | 3 | $218 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $200 |
| Astellas Pharma US Inc | 2 | $117 |
| Incyte Corporation | 2 | $115 |
| Clovis Oncology, Inc. | 1 | $99 |
| Octapharma USA, Inc. | 5 | $97 |
| Lilly USA, LLC | 1 | $75 |
| CSL Behring | 3 | $43 |
| Johnson & Johnson | 3 | $42 |
| Pfizer | 3 | $41 |
| Novartis | 2 | $40 |
| Genentech USA, Inc. | 2 | $36 |
| Array Biopharma Inc | 2 | $30 |
| Merck | 1 | $27 |
| Tersera Therapeutics LLC | 2 | $27 |
| EMD Serono, Inc. | 2 | $25 |
| Eisai Inc. | 1 | $24 |
| Gilead | 1 | $19 |
| Myriad Genetic Laboratories, Inc. | 1 | $18 |
| Stemline Therapeutics Inc. | 1 | $18 |
| Aurobindo Pharma USA, Inc. | 1 | $18 |
| Beigene USA, Inc. | 1 | $16 |
| GSK | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $14 |
| GE HealthCare | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Apellis Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$1,742 in reported general payments places this provider in the 20th percentile of 507 medical oncology providers in Florida.
Other medical oncology in Gainesville
- John WingardGainesville$106K
- Vijay PatelGainesville$72K
- Neil LoveMiami$5.6M
- Mahdi TahaBoca Raton$1.7M
- Raji ShameemOrlando$1.3M
- Mohammad JahanzebBoca Raton$1.3M
- Michel VelezOrlando$927K
- Yuanbin ChenOrlando$810K
- Reshma MahtaniPlantation$608K
- Rebecca MorooseOrlando$543K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.